Antibiotic OPEC: The Shadow Cartels Monetizing the Ruins of the Strait of Hormuz
In the last fourteen days, the cost of keeping a feverish child stable in a…
Market Watch
Short updates and news on pharmaceutical markets.
The 21% Correction: Why Public Markets Are No Longer Buying Biotech Platforms Without Clinical Anchors
The biotech markets of early 2026 have become a theater of the extreme, where the…
Stop Searching, Start Connecting: Your Global API & FDF Hub
If you’ve been in the pharma business for a while, you know that finding a…
Checkbook Darwinism: Why Merck and Roche Are Paying ‘Panic Premiums’ to Avert Extinction
The pharmaceutical sector has officially transitioned from cautious capital preservation to a state of aggressive,…
Regulatory Shock Trades: How FDA Letters Move Billions Before Lunch
CRL Regulatory Shock Trades: How FDA Letters Move Billions Before Lunch No fireworks. A 7:12…
Britain’s Big Pharma Showdown: NHS Drug Levy Sparks £11 Billion R&D Exodus Threat
LONDON, June 4, 2025 – A storm is brewing between the UK’s National Health Service…
Dirty Pills and Empty Shelves: How Outsourcing Broke America’s Drug Supply
Imagine being told your chemotherapy is postponed because the only factory making the drug was…
Unmet Opportunities: Analyzing the FDA List of Drugs Without Approved Generics
The FDA’s Off-Patent, Off-Exclusivity Drugs without an Approved Generic list highlights pharmaceutical products that are…